Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Lymphoma, Mantle-Cell 1Gastrointestinal Neoplasms 1Gastroesophageal Reflux 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Adenomatous Polyposis Coli 1

Interventions

Specimen Handling 3Biopsy 3Endoscopy, Gastrointestinal 2trifluridine tipiracil drug combination 1obeticholic acid 1Thiamine 1Sirolimus 1Sigmoidoscopy 1Oxaliplatin 1Nivolumab 1Leucovorin 1Gastroscopy 1Fluorouracil 1Exercise Therapy 1Endoscopy, Digestive System 1Colonoscopy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenomatous Polyposis Coli × Endoscopy, Digestive System × 90 days × Clear all
NCT06557733 2026-05-13

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡